e-learning
resources
Virtual 2020
Pre-Congress Content
Monitoring of patients with COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The change of the activity of the blood-salivary barrier (BSB) in patients with COPD
S. Soodaeva (Moscow, Russian Federation), N. Kubysheva (Kazan, Russian Federation), . Klimanov (Moscow, Russian Federation), . Nikitina (Moscow, Russian Federation), . Popova (Moscow, Russian Federation), T. Li (Moscow, Russian Federation), . Novoselov (Pushchino, Russian Federation)
Source:
Virtual Congress 2020 – Monitoring of patients with COPD
Session:
Monitoring of patients with COPD
Session type:
E-poster session
Number:
1040
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Soodaeva (Moscow, Russian Federation), N. Kubysheva (Kazan, Russian Federation), . Klimanov (Moscow, Russian Federation), . Nikitina (Moscow, Russian Federation), . Popova (Moscow, Russian Federation), T. Li (Moscow, Russian Federation), . Novoselov (Pushchino, Russian Federation). The change of the activity of the blood-salivary barrier (BSB) in patients with COPD. 1040
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The survival effect of physical activity in patients with COPD: every step counts.
Source: International Congress 2017 – The importance of physical activity in patients with COPD
Year: 2017
Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF)
Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis
Year: 2020
Is physical activity a determinant for change in FEV1 in COPD patients? A prospective cohort study
Source: International Congress 2015 – Best abstracts in physical activity in chronic lung diseases
Year: 2015
Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Tele-coaching to promote physical activity in patients with COPD: Evaluation by patients
Source: International Congress 2015 – Rehabilitation, exercise, hospitalisation and COPD
Year: 2015
COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
The effect of lung volume reduction on the success of physical activity coaching in patients with severe COPD
Source: Virtual Congress 2020 – Physical activity and chronic lung disease: once a new kid, now growing up
Year: 2020
Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
The loss of the beneficial effect of deep inspiration (DI) in COPD is associated with severity of disease
Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring
Year: 2007
Physical activity determinants in COPD patients in the community
Source: International Congress 2016 – Best abstracts in physical activity and telemedicine
Year: 2016
Gender differences in formation of endothelial dysfunction (ED) extension in COPD patients
Source: Annual Congress 2011 - COPD mechanisms
Year: 2011
ACTIVATE: effect of aclidinium/formoterol on physical activity in patients with COPD
Source: International Congress 2017 – COPD management
Year: 2017
LSC - 2020 - The lung DNA methylation profile of patients with COPD: relationship with smoking and airflow limitation severity.
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
LATE-BREAKING ABSTRACT: A large airway phenotype among symptomatic smokers with preserved pulmonary function: The subpopulations and intermediate outcome measures in COPD study (SPIROMICS)
Source: International Congress 2016 – Mixed-up imaging of various chest diseases
Year: 2016
Hyperinflation and its effects on upper and lower extremities exercise in patients with COPD and controls. A longitudinal study
Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease
Year: 2015
Physical activity in patients with COPD: a reference frame based on functional capacity
Source: International Congress 2018 – Determinants of physical activity behaviour in patients with COPD and the physiotherapist as a physical activity coach
Year: 2018
A comparison of exercise capacity, physical activity level and balance in COPD patients with and without frailty
Source: International Congress 2019 – Exercise tolerance and its determinants across pathologies
Year: 2019
How to stage airflow limitation (AL) in patients with stable COPD?
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019
COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012
Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes
Source: International Congress 2015 – Different data in COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept